drugset
drugset / Press release

HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG

2021-07-07 · HanAll BioPharma Co., Ltd. · original hanall.com ↗

Batoclimab · results

HanAll Biopharma (KRX: 009420.KS) today announced that its partner for  HL161 (batoclimab) & HL036 (tanfanercept) ​, Harbour BioMed, reported  positive topline results from Phase 2 of batoclimab in MG.   - HBM press release link:  https:// www.harbourbiomed.com/news/157.html

The release as fetched from its publisher. hanall.com ↗